A Bioequivalence Study Of 8 Mg Fesoterodine Extended-Release Tablets (Toviaz™) In Healthy Subjects

Clinical trial NCT00902681 · COMPLETED

Trial details

NCT number: NCT00902681
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Treatment of Overactive Bladder

Start date: 2009-06-01
Primary completion: 2009-08-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.